The Ser9Gly polymorphism of the dopamine D3 receptor gene and risk of schizophrenia: An association study and a large meta-analysis

Schizophrenia Research

Volumn 101, Issue 1-3, 2008, Pages 26-35

  Ma, Gang ^a,b,c   He, ZangDong ^a,b,c   Fang, WenLi ^a,b   Tang, Wei ^a,c   Huang, Ke ^a,c   Li, ZhiQiang ^a,c   He, Guang ^a   Xu, YiFeng ^d   Feng, GuoYin ^d   Zheng, Tao ^e   Zhou, Jian ^a,c   He, Lin ^a,c   Shi, YongYong ^a,b,c  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Changning Mental Health Center   (China)

^c Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^d SHANGHAI MENTAL HEALTH CENTER   (China)

^e SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Association; DRD3; Genetic polymorphisms; Meta analysis; Schizophrenia

Indexed keywords

GLYCINE; SERINE;

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DOPAMINE D3 RECEPTOR GENE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; RECEPTOR GENE; RISK ASSESSMENT; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; CASE-CONTROL STUDIES; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GLYCINE; HUMANS; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D3; RISK; SCHIZOPHRENIA; SERINE;

EID: 42749095256     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2007.11.041     Document Type: Article

References (69)

1. Ambrosio A.M., Kennedy J.L., et al. Family association study between DRD2 and DRD3 gene polymorphisms and schizophrenia in a Portuguese population. Psychiatry Res. 125 3 (2004) 185-191
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 4th edition (1994) American Psychiatric Association, Washington, D.C.
3. Anney R.J., Rees M.I., et al. Characterisation, mutation detection, and association analysis of alternative promoters and 5′ UTRs of the human dopamine D3 receptor gene in schizophrenia. Mol Psychiatry 7 5 (2002) 493-502
4. Asherson P., Mant R., et al. Linkage, association and mutational analysis of the dopamine D3 receptor gene in schizophrenia. Mol Psychiatry 1 2 (1996) 125-132
5. Baritaki S., Rizos E., et al. Association between schizophrenia and DRD3 or HTR2 receptor gene variants. Eur J Hum Genet. 12 7 (2004) 535-541
6. Cagle M., Peacock M.L., Mathay J.G., Sunnenberg C., Tandon R., Meltzer H., et al. Dopamine D3 receptor polymorphism in schizophrenia: importance of evaluating control subjects. Am J Hum Genet. 53 (1993) 783
7. Carlsson A. The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1 (1988) 179-186
8. Chen C.H., Liu M.Y., Wei F.C., Koong F.J., Hwu H.G., and Hsiao K.J. Further evidence of no association between Ser9Gly polymorphism of dopamine D3 receptor gene and schizophrenia. Am J Med Genet. 21 74 (1997) 40-43
9. Cochran W.G. The combinations of estimates from different experiments. Biometrics 10 (1954) 101-129
10. Cordeiro Q.J., Junqueira R., and Vallada H. Study of association between the Ser-9-Gly polymorphism of the D3 dopaminergic receptor and schizophrenia [Article in Portuguese]. Arq. Neuropsiquiatr. 59 (2001) 219-222
11. Crocq M.A., Mant R., Asherson P., Williams J., Hode Y., Mayerova A., Collier D., Lannfelt L., Sokoloff P., and Schwartz J.C. Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J. Med. Genet. 29 (1992) 858-860
12. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Contr. Clin. Trials 7 3 (1986) 177-188
13. Di Bella D., Catalano M., et al. Distribution of the MscI polymorphism of the dopamine D3 receptor in an Italian psychotic population. Psychiatr. Genet. 4 1 (1994) 39-42
14. Dubertret C., Gorwood P., Ades J., Feingold J., Schwartz J.C., and Sokoloff P. Meta-analysis of DRD3 gene and schizophrenia: ethnic heterogeneity and significant association in Caucasians. Am. J. Med. Genet. 81 4 (1998) 318-322
15. Durany N., Thome J., et al. Homozygosity at the dopamine D3 receptor gene in schizophrenic patients. Neurosci. Lett. 220 3 (1996) 151-154
16. Ebstein R.P., Macciardi F., et al. Evidence for an association between the dopamine D3 receptor gene DRD3 and schizophrenia. Hum. Hered. 47 1 (1997) 6-16
17. Egger M., Davey Smith G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 7109 (1997) 629-634
18. *Power: a general power analysis program. Behav. Res. Meth. Instrum. Comput. 28 (1996) 1-11
19. Fathalli F., Rouleau G.A., et al. No association between the DRD3 Ser9Gly polymorphism and schizophrenia. Schizophr Res. 98 1-3 (2008) 98-104
20. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured clinical interview for DSM-IV-TR Axis I disorders, research version, patient edition (SCID-I/P). Biometrics Research (2001), New York State Psychiatric Institute, New York
21. Gaitonde E.J., Morris A., Sivagnanasundaram S., McKennam P.J., Hunt D.M., and Mollon J.D. Assessment of association of D3 dopamine receptor MscI polymorphism with schizophrenia: analysis of symptom ratings, family history, age at onset, and movement disorders. Am. J. Med. Genet. 20 67 (1996) 455-458
22. Gottesman I.I., and Shields J. Schizophrenia, the epigenetic puzzle (1982), Cambridge University Press, Cambridge
23. Guo N., Klitenick M.A., Tham C.S., and Fibiger H.C. Receptor mechanisms mediating clozapine-induced c-fos expression in the forebrain. Neuroscience 65 (1995) 747-756
24. Hawi Z., McCabe U., Straub R.E., O'Neill A., Kendler K.S., Walsh D., and Gill M. Examination of new and reported data of the DRD3/MscI polymorphism: no support for the proposed association with schizophrenia. Mol. Psychiatry 3 (1998) 150-155
25. Inada T., Sugita T., et al. Dopamine D3 receptor gene polymorphism and the psychiatric symptoms seen in first-break schizophrenic patients. Psychiatr. Genet. 5 3 (1995) 113-116
26. Ishiguro H., Okuyama Y., Toru M., and Arinami T. Mutation and association analysis of the 5 V region of the dopamine D3 receptor gene in schizophrenia patients: identification of the Ala38Thr polymorphism and suggested association between DRD3 haplotypes and schizophrenia. Mol. Psychiatry 5 4 (2000) 433-438
27. Janowsky D.A., and Davis J.M. Methylphenidate, dextroamphetamine, and levamphetamine: effects on schizophrenic symptoms. Arch. Gen. Psychiatry 33 (1976) 304-308
28. Jonsson E., Lannfelt L., Sokoloff P., Schwartz J.C., and Sedvall G. Lack of association between schizophrenia and alleles in the dopamine D3 receptor gene. Acta Psychiatr. Scand. 87 (1993) 345-349
29. Jonsson E.G., Flyckt L., Burgert E., Crocq M.A., Forslund K., Mattila-Evenden M., Rylander G., Asberg M., Nimgaonkar V.L., Edman G., Bjerkenstedt L., Wiesel F.A., and Sedvall G.C. Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis. Psychiatr. Genet. 13 (2003) 1-12
30. Jonsson E.G., Kaiser R., Brockmoller J., Nimgaonkar V.L., and Crocq M.A. Metaanalysis of the dopamine D3 receptor gene (DRD3) Ser9Gly variant and schizophrenia. Psychiatr. Genet. 14 (2004) 9-12
31. Joober R., Toulouse A., Benkelfat C., Lal S., Bloom D., Labelle A., Lalonde P., Turecki G., and Rouleau G.A. DRD3 and DAT1 genes in schizophrenia: an association study. J Psychiatr. Res. 34 (2000) 285-291
32. Kennedy J.L., Billett E.A., et al. Association study of dopamine D3 receptor gene and schizophrenia. Am. J. Med. Genet. 60 6 (1995) 558-562
33. Krebs M.O., Sautel F., et al. Dopamine D3 receptor gene variants and substance abuse in schizophrenia. Mol. Psychiatry 3 4 (1998) 337-341
34. Kremer I., Rietschel M., Dobrusin M., Mujaheed M., Murad I., Blanaru M., Bannoura I., Muller D.J., Schulze T.G., Reshef A., Gathas S., Schwab S., Wildenauer D., Bachner-Melman R., Belmaker R.H., Maier W., and Ebstein R.P. No association between the dopamine D3 receptor Bal I polymorphism and schizophrenia in a family-based study of a Palestinian Arab population. Am. J. Med. Genet. 4 96 (2000) 778-780
35. Lannfelt T., Sokoloff P., Martres M.P., Pilon C., Giros B., Jonsson E., Sedvall G., and Schwartz J.C. Amino acid substitution in the dopamine D3 receptor as useful polymorphism for investigating psychiatric disorders. Psychiatr. Genet. 2 (1992) 249-256
36. Laurent C., Savoye C., Samolyk D., Meloni R., Mallet J., Campion D., Martinez M., D'Amato T., Bastard C., and Dollfus S. Homozygosity at the dopamine D3 receptor locus is not associated with schizophrenia. J. Med. Genet. 31 3 (1994) 260
37. Le Coniat M., Sokoloff P., Hillion J., Martres M.P., Giros B., Pilon C., Schwartz J.C., and Berger R. Chromosomal localization of the human D3 dopamine receptor gene. Hum. Genet. 87 (1991) 618-620
38. Lohmueller K.E., Pearce C.L., Pike M., Lander E.S., and Hirschhorn J.N. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat. Genet. 33 2 (2003) 177-182
39. Lorenzo C.V., Baca-Garcia E., et al. No association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and schizophrenia in a Spanish sample. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144 3 (2007) 344-346
40. Lovlie R., Thara R., et al. Ser9Gly dopamine D3 receptor polymorphism and spontaneous dyskinesia in never-medicated schizophrenic patients. Mol Psychiatry 6 1 (2001) 6-7
41. Malhotra A.K., Goldman D., Buchanan R.W., Rooney W., Clifton A., Kosmidis M.H., Breier A., and Pickar D. The dopamine D3 receptor (DRD3) Ser9Gly polymorphism and schizophrenia: a haplotype relative risk study and association with clozapine response. Mol. Psychiatry 3 (1998) 72-75
42. Maziade M., Martinez M., et al. Childhood/early adolescence-onset and adult-onset schizophrenia. Heterogeneity at the dopamine D3 receptor gene. Br. J. Psychiatry 170 (1997) 27-30
43. McGuffin P. Genetics of schizophrenia. In: Bebbington P., and McGuffin P. (Eds). Schizophrenia, the major issues (1988), Heinemann, London 107-126
44. Meszaros K., Lenzinger E., et al. Association study of schizophrenia spectrum disorders and dopamine D3 receptor gene: is schizoaffective disorder special?. Psychiatr. Res. 96 2 (2000) 179-183
45. Morimoto K., Miyatake R., et al. Delusional disorder: molecular genetic evidence for dopamine psychosis. Neuropsychopharmacology 26 6 (2002) 794-801
46. Nanko S., Sasaki T., et al. A study of the association between schizophrenia and the dopamine D3 receptor gene. Hum. Genet. 92 4 (1993) 336-338
47. Ohara K., Nakamura Y., et al. Polymorphisms of dopamine D2-like (D2, D3, and D4) receptors in schizophrenia. Biol. Psychiatry 40 12 (1996) 1209-1217
48. Pulver A.E., Mulle J., Nestadt G., et al. Genetic heterogeneity in schizophrenia: stratification of genome scan data using co-segregating related phenotypes. Mol. Psychiatry 5 (2000) 650-653
49. Rietschel M., Nothen M.M., Albus M., Maier W., Minges J., Bondy B., Korner J., Hemmer S., Fimmers R., Moller H.J., Wildenauer D., and Propping P. Dopamine D3 receptor Gly9/Ser9 polymorphism and schizophrenia: no increased frequency of homozygosity in German familial cases. Schizophr. Res. 20 (1996) 181-186
50. Rothschild L.G., Badner J., Cravchik A., Gershon E.S., and Gejman P.V. No association detected between a D3 receptor gene-expressed variant and schizophrenia. Am. J. Med. Genet. 9 67 (1996) 232-234
51. Rybakowski J.K., Borkowska A., et al. Dopamine D3 receptor (DRD3) gene polymorphism is associated with the intensity of eye movement disturbances in schizophrenic patients and healthy subjects. Mol. Psychiatry 6 6 (2001) 718-724
52. Saha N., Tsoi W.F., Low P.S., Basair J., and Tay J.S. Lack of association of the dopamine D3 receptor gene polymorphism (BalI) in Chinese schizophrenic males. Psychiatr. Genet. 4 (1994) 201-204
53. Schmauss C., Haroutunian V., Davis K.L., and Davidson M. Selective loss of dopamine D3-type receptor mRNA expression in parietal and motor cortices of patients with chronic schizophrenia. Proc. Natl. Acad. Sci. USA 90 (1993) 8942-8946
54. Seeman P., and van Tol H.M. Dopamine receptor pharmacology. Trends Pharmacol. Sci. 15 (1994) 264-270
55. Shaikh S., Collier D.A., et al. Allelic association between a Ser-9-Gly polymorphism in the dopamine D3 receptor gene and schizophrenia. Hum. Genet. 97 6 (1996) 714-719
56. Sham P.C., and Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann. Hum. Genet. 59 (1995) 97-105
57. Shi Y.Y., and He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 15 (2005) 97-98
58. Sivagnanasundaram S., Morris A.G., Gaitonde E.J., McKenna P.J., and Mollon J.D. A cluster of single nucleotide polymorphisms in the 5 V-leader of the human dopamine D3 receptor gene (DRD3) and its relationship to schizophrenia. Neurosci. Lett. 279 (2000) 13-16
59. Sokoloff P., Andrieux M., Besancon R., Pilon C., Martres M.P., Giros B., et al. Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor. Eur. J. Pharmacol. 225 4 (1992) 331-337
60. Sokoloffm P., Girosm B., Martresm M.P., Bouthenetm M.L., and Schwartzm J.C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347 (1990) 146-151
61. Spurlock G., Williams J., et al. European Multicentre Association Study of Schizophrenia: a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms. Am. J. Med. Genet. 81 1 (1998) 24-28
62. Staddon S., Arranz M.J., Mancama D., Perez-Nievas F., Arrizabalaga I., Anney R., Buckland P., Elkin A., Osborne S., Munro J., Mata I., and Kerwin R.W. Association between dopamine D3 receptor gene polymorphisms and schizophrenia in an isolate population. Schizophr. Res. 1 73 (2005) 49-54
63. Talkowski M.E., Mansour H., Chowdari K.V., Wood J., Butler A., Varna P.G., Prasad S., Semwal P., Bhatia T., Deshpande S., Devlin B., Thelma B.K., and Nimgaonkar V.L. Novel, replicated associations between dopamine D3 receptor gene polymorphisms and schizophrenia in two independent samples. Biol. Psychiatry 60 (2006) 570-577
64. Tanaka T., Igarashi S., Onodera O., Tanaka H., Takahashi M., Maeda M., Kameda K., Tsuji S., and Ihda S. Association study between schizophrenia and dopamineD3receptor gene polymorphism. Am. J. Med. Genet. 26 67 (1996) 366-368
65. Ventriglia M., Bocchio Chiavetto L., et al. Allelic variation in the human prodynorphin gene promoter and schizophrenia. Neuropsychobiology 46 1 (2002) 17-21
66. Virgos C., Martorell L., et al. Association study of schizophrenia with polymorphisms at six candidate genes. Schizophr. Res. 49 1-2 (2001) 65-71
67. Williams J., Spurlock G., Holmans P., Mant R., Murphy K., Jones L., et al. A meta-analysis and transmission disequilibrium study of association between the dopamine D3 receptor gene and schizophrenia. Mol. Psychiatry 3 2 (1998) 141-149
68. Woolf B. On estimating the relation between blood group and disease. Ann. Hum. Genet. 19 4 (1955) 251-253
69. Yang L., Li T., Wiese C., Lannfelt L., Sokoloff P., Xu C.T., Zeng Z., Schwartz J.C., Liu X., and Moises H.W. No association between schizophrenia and homozygosity at the D3 dopamine receptor gene. Am. J. Med. Genet. 15 48 (1993) 83-86